Nuclear hormone receptor co-repressors: structure and function. 2012

Peter J Watson, and Louise Fairall, and John W R Schwabe
Henry Wellcome Laboratories of Structural Biology, Department of Biochemistry, University of Leicester, Leicester LE1 9HN, UK.

Co-repressor proteins, such as SMRT and NCoR, mediate the repressive activity of unliganded nuclear receptors and other transcription factors. They appear to act as intrinsically disordered "hub proteins" that integrate the activities of a range of transcription factors with a number of histone modifying enzymes. Although these co-repressor proteins are challenging targets for structural studies due to their largely unstructured character, a number of structures have recently been determined of co-repressor interaction regions in complex with their interacting partners. These have yielded considerable insight into the mechanism of assembly of these complexes, the structural basis for the specificity of the interactions and also open opportunities for targeting these interactions therapeutically.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006655 Histone Deacetylases Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes. Class I Histone Deacetylases,Class II Histone Deacetylases,HDAC Proteins,Histone Deacetylase,Histone Deacetylase Complexes,Complexes, Histone Deacetylase,Deacetylase Complexes, Histone,Deacetylase, Histone,Deacetylases, Histone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D046912 Multiprotein Complexes Macromolecular complexes formed from the association of defined protein subunits. Macromolecular Protein Complexes,Complexes, Macromolecular Protein,Complexes, Multiprotein,Protein Complexes, Macromolecular
D054730 Protein Interaction Domains and Motifs Protein modules with conserved ligand-binding surfaces which mediate specific interaction functions in SIGNAL TRANSDUCTION PATHWAYS and the specific BINDING SITES of their cognate protein LIGANDS. Protein Interaction Domains,Protein Interaction Motifs,Binding Motifs, Protein Interaction,Protein Interaction Binding Motifs,Protein-Protein Interaction Domains,Domain, Protein Interaction,Domain, Protein-Protein Interaction,Domains, Protein Interaction,Domains, Protein-Protein Interaction,Motif, Protein Interaction,Motifs, Protein Interaction,Protein Interaction Domain,Protein Interaction Motif,Protein Protein Interaction Domains,Protein-Protein Interaction Domain
D056971 Nuclear Receptor Co-Repressor 1 A nuclear protein that regulates the expression of genes involved in a diverse array of processes related to metabolism and reproduction. The protein contains three nuclear receptor interaction domains and three repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 2. Nuclear Factor RIP140,Nuclear Receptor Co-Repressor RIP140,RIP140 Repressor,Receptor Interacting Protein 140,Retinoid X Receptor-Interacting Protein 13,Nuclear Receptor Co Repressor 1,Nuclear Receptor Co Repressor RIP140,Retinoid X Receptor Interacting Protein 13
D056985 Nuclear Receptor Co-Repressor 2 A nuclear co-repressor protein that shows specificity for RETINOIC ACID RECEPTORS and THYROID HORMONE RECEPTORS. The dissociation of this co-repressor from nuclear receptors is generally ligand-dependent, but can also occur by way of its phosphorylation by members of the MAP KINASE SIGNALING SYSTEM. The protein contains two nuclear receptor interaction domains and four repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 1. SMRT Co-repressor,Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor,T3 Receptor-associating Factor,TRAC Co-repressor,Co-repressor, SMRT,Co-repressor, TRAC,Nuclear Receptor Co Repressor 2,Receptor-associating Factor, T3,SMRT Co repressor,T3 Receptor associating Factor,TRAC Co repressor

Related Publications

Peter J Watson, and Louise Fairall, and John W R Schwabe
February 2005, The Journal of steroid biochemistry and molecular biology,
Peter J Watson, and Louise Fairall, and John W R Schwabe
August 2006, BMC cell biology,
Peter J Watson, and Louise Fairall, and John W R Schwabe
February 1996, European journal of endocrinology,
Peter J Watson, and Louise Fairall, and John W R Schwabe
January 2000, Biochemical Society transactions,
Peter J Watson, and Louise Fairall, and John W R Schwabe
September 2003, Current opinion in drug discovery & development,
Peter J Watson, and Louise Fairall, and John W R Schwabe
May 1995, Molecular endocrinology (Baltimore, Md.),
Peter J Watson, and Louise Fairall, and John W R Schwabe
November 2002, The Journal of biological chemistry,
Peter J Watson, and Louise Fairall, and John W R Schwabe
May 2000, Steroids,
Peter J Watson, and Louise Fairall, and John W R Schwabe
January 2001, Current topics in microbiology and immunology,
Peter J Watson, and Louise Fairall, and John W R Schwabe
February 1990, Seminars in cancer biology,
Copied contents to your clipboard!